-
Thematic Analysis
NewPackaging M&A Deals, Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Packaging Sector
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMB-101 in Seizures
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMB-101 in Seizures report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMB-101 in Seizures Drug Details: BMA-101 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Amlodipine in Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Amlodipine in Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amlodipine in Hypertension Drug Details: Amlodipine is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MRNA-1365 in Respiratory Syncytial Virus (RSV) Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MRNA-1365 in Respiratory Syncytial Virus (RSV) Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MRNA-1365 in Respiratory Syncytial Virus (RSV) Infections Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MRNA-1365 in Human Metapneumovirus Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MRNA-1365 in Human Metapneumovirus Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MRNA-1365 in Human Metapneumovirus Infections Drug Details: mRNA-1365 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMB-101 in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMB-101 in Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMB-101 in Alzheimer's Disease Drug Details: BMA-101 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Smallpox Vaccine in Monkeypox
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Smallpox Vaccine in Monkeypox report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Smallpox Vaccine in Monkeypox Drug Details: Smallpox vaccine (ACAM2000) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LR-19114 in Hepatitis B
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LR-19114 in Hepatitis B report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LR-19114 in Hepatitis B Drug Details: LBVD is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LR-19114 in Poliomyelitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LR-19114 in Poliomyelitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LR-19114 in Poliomyelitis Drug Details: LBVD is under development for the prevention...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LR-19114 in Pertussis (Whooping Cough)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LR-19114 in Pertussis (Whooping Cough) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LR-19114 in Pertussis (Whooping Cough) Drug Details: LBVD is under...